Insider · CIK 0001775429

Vignola Mark J.

Reports to the SEC for 3 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001775429

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-01-06	TERNTerns Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−9,059 sh	$5.80	−$52.5K	74,752
2025-01-02	TERNTerns Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−8,129 sh	$5.72	−$46.5K	83,811
2024-09-10	TERNTerns Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	$5.36	+$53.6K	101,940
2024-09-10	TERNTerns Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−10K sh	$11.00	−$110K	91,940
2024-09-10	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	55,000
2024-05-31	TERNTerns Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+4,791 sh	$4.44	+$21.3K	91,940
2024-01-23	TERNTerns Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+68.8K sh	—	—	87,149
2024-01-23	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+138K sh	—	—	137,500
2023-11-30	TERNTerns Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+743 sh	$3.78	+$2,808.54	18,399
2023-05-31	TERNTerns Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+9,997 sh	$1.41	+$14.1K	17,656
2023-02-01	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+360K sh	—	—	360,000
2022-11-30	TERNTerns Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+3 sh	$1.41	+$4.23	7,659
2022-05-31	TERNTerns Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+7,656 sh	$1.47	+$11.3K	7,656
2022-01-26	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+65K sh	—	—	65,000
2021-09-28	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+120K sh	—	—	120,000
2019-05-13	APLTApplied Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+34.1K sh	—	—	34,104

Recent filings

Accepted (ET)
Jan 64
Vignola Mark J.0001562180-25-000220
SEC(opens sec.gov)
Sep 124
Vignola Mark J.0001562180-24-006794
SEC(opens sec.gov)
Jun 44
Vignola Mark J.0001562180-24-004665
SEC(opens sec.gov)
Jan 254
Vignola Mark J.0001562180-24-000639
SEC(opens sec.gov)
Dec 44
Vignola Mark J.0001562180-23-008065
SEC(opens sec.gov)
Jun 24
Vignola Mark J.0001562180-23-004748
SEC(opens sec.gov)
Feb 34
Vignola Mark J.0001562180-23-000982
SEC(opens sec.gov)
Jun 84
Vignola Mark J.0001562180-22-004951
SEC(opens sec.gov)
Jan 284
Vignola Mark J.0001567619-22-002013
SEC(opens sec.gov)
Sep 304
Vignola Mark J.0000899243-21-038549
SEC(opens sec.gov)
May 154
Vignola Mark J.0001209191-19-030088
SEC(opens sec.gov)

Companies

Address

C/O KORSANA BIOSCIENCES, INC. 203 CRESCENT STREET, SUITE 503

WALTHAM, MA, 02453